Literature DB >> 4131053

Letter: Ampicillin-resistant Shiga bacillus in Bangladesh.

M M Rahaman, I Huo, C R Dey, A K Kibriya, G Curlin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4131053     DOI: 10.1016/s0140-6736(74)93171-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Shigellosis in children--prevalence of subgroups and antibiotic resistance.

Authors:  D V Kaundinya; A S Damle; R P Fule
Journal:  Indian J Pediatr       Date:  1985 Nov-Dec       Impact factor: 1.967

2.  Drug resistance in Shigella dysenteriae, S flexneri and S boydii in England and Wales: increasing incidence of resistance to trimethoprim.

Authors:  R J Gross; E J Threlfall; L R Ward; B Rowe
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-10

3.  Fluoroquinolone resistance linked to both gyrA and parC mutations in the quinolone resistance-determining region of Shigella dysenteriae type 1.

Authors:  Kaisar A Talukder; Bijay K Khajanchi; Mohammad A Islam; Zhahirul Islam; Dilip K Dutta; Mustafizur Rahman; Haruo Watanabe; Gopinath B Nair; David A Sack
Journal:  Curr Microbiol       Date:  2006-01-31       Impact factor: 2.188

4.  Characterization of an R-plasmid associated with ampicillin resistance in Shigella dysenteriae type 1 isolated from epidemics.

Authors:  J H Crosa; J Olarte; L J Mata; L K Luttropp; M E Peñaranda
Journal:  Antimicrob Agents Chemother       Date:  1977-03       Impact factor: 5.191

5.  Comparative efficacies of pivmecillinam and ampicillin in acute shigellosis.

Authors:  I Kabir; M M Rahaman; S M Ahmed; S Q Akhter; T Butler
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

6.  Comparative efficacies of single intravenous doses of ceftriaxone and ampicillin for shigellosis in a placebo-controlled trial.

Authors:  I Kabir; T Butler; A Khanam
Journal:  Antimicrob Agents Chemother       Date:  1986-04       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.